NEPEMEDIC: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NEPEMEDIC
Largest movements
- Tangible fixed assets -€7,670
down €7,670 (-2.3%), from €333,248 to €325,578
of which Other tangible fixed assets: -€9,446
- Cash +€4,121
up €4,121 (+5926.6%), from €70 to €4,190
mainly Net result for the year (+€45,901) and Depreciation (+€7,670)
- Reserves +€45,068
up €45,068 (+18.0%), from €250,938 to €296,006
of which Distributable reserves: +€42,492
- Other debts -€28,207
down €28,207 (-46.5%), from €60,656 to €32,449
- Current portion of long-term debt -€15,747
no longer reported in 2025 (was €15,747)
- Provisions +€5,500
new in 2025: €5,500
- Gross operating margin +€36,750
up €36,750 (+106.6%), from €34,488 to €71,238
- Taxes +€4,839
up €4,839 (+72.6%), from €6,664 to €11,503
- Financial charges -€1,560
down €1,560 (-56.9%), from €2,740 to €1,180
- Other operating charges -€1,495
down €1,495 (-78.9%), from €1,895 to €400
- Depreciation -€927
down €927 (-10.8%), from €8,598 to €7,670
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €345,508 | €346,355 | +€847 | +0.2% |
| Fixed assets | 21/28 | €334,248 | €326,578 | -€7,670 | -2.3% |
| Tangible fixed assets | 22/27 | €333,248 | €325,578 | -€7,670 | -2.3% |
| Land and buildings | 22 | €323,000 | €325,424 | +€2,424 | +0.8% |
| Plant, machinery and equipment | 23 | - | €154 | +€154 | |
| Furniture and vehicles | 24 | €802 | - | -€802 | |
| Other tangible fixed assets | 26 | €9,446 | - | -€9,446 | |
| Financial fixed assets | 28 | €1,000 | €1,000 | = | 0.0% |
| Current assets | 29/58 | €11,260 | €19,777 | +€8,517 | +75.6% |
| Amounts receivable within one year | 40/41 | €9,864 | €12,374 | +€2,510 | +25.4% |
| Trade receivables | 40 | - | €539 | +€539 | |
| Other amounts receivable | 41 | €9,864 | €11,835 | +€1,971 | +20.0% |
| Current investments | 50/53 | €192 | - | -€192 | |
| Cash at bank and in hand | 54/58 | €70 | €4,190 | +€4,121 | +5926.6% |
| Deferred charges and accrued income | 490/1 | €1,134 | €3,212 | +€2,078 | +183.3% |
| Total equity and liabilities | 10/49 | €345,508 | €346,355 | +€847 | +0.2% |
| Equity | 10/15 | €263,338 | €308,406 | +€45,068 | +17.1% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €250,938 | €296,006 | +€45,068 | +18.0% |
| Non-distributable reserves | 130/1 | €13,924 | - | -€13,924 | |
| Reserves not available under the articles | 1311 | €13,924 | - | -€13,924 | |
| Tax-exempt reserves | 132 | - | €16,500 | +€16,500 | |
| Distributable reserves | 133 | €237,013 | €279,506 | +€42,492 | +17.9% |
| Provisions and deferred taxes | 16 | - | €5,500 | +€5,500 | |
| Deferred taxes | 168 | - | €5,500 | +€5,500 | |
| Amounts payable | 17/49 | €82,170 | €32,449 | -€49,721 | -60.5% |
| Amounts payable within one year | 42/48 | €82,170 | €32,449 | -€49,721 | -60.5% |
| Current portion of amounts payable after more than one year | 42 | €15,747 | - | -€15,747 | |
| Financial debts | 43 | €1,219 | - | -€1,219 | |
| Credit institutions | 430/8 | €1,219 | - | -€1,219 | |
| Trade debts | 44 | €1,244 | - | -€1,244 | |
| Suppliers | 440/4 | €1,244 | - | -€1,244 | |
| Taxes, remuneration and social security | 45 | €3,304 | - | -€3,304 | |
| Taxes | 450/3 | €3,304 | - | -€3,304 | |
| Other amounts payable | 47/48 | €60,656 | €32,449 | -€28,207 | -46.5% |
| Non-recurring operating income | 76A | - | €22,000 | +€22,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,598 | €7,670 | -€927 | -10.8% |
| Other operating charges | 640/8 | €1,895 | €400 | -€1,495 | -78.9% |
| Gross operating margin | 9900 | €34,488 | €71,238 | +€36,750 | +106.6% |
| Operating profit (loss) | 9901 | €23,996 | €63,168 | +€39,172 | +163.2% |
| Financial income | 75/76B | €1,128 | €916 | -€212 | -18.8% |
| Recurring financial income | 75 | €1,128 | €916 | -€212 | -18.8% |
| Financial charges | 65/66B | €2,740 | €1,180 | -€1,560 | -56.9% |
| Recurring financial charges | 65 | €2,740 | €1,180 | -€1,560 | -56.9% |
| Profit (loss) for the period before taxes | 9903 | €22,384 | €62,904 | +€40,520 | +181.0% |
| Transfer to deferred taxes | 680 | - | €5,500 | +€5,500 | |
| Income taxes | 67/77 | €6,664 | €11,503 | +€4,839 | +72.6% |
| Profit (loss) for the period | 9904 | €15,720 | €45,901 | +€30,181 | +192.0% |
| Transfer to tax-exempt reserves | 689 | - | €16,500 | +€16,500 | |
| Profit (loss) for the period to be appropriated | 9905 | €15,720 | €29,401 | +€13,681 | +87.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.